Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2011-01-31
2012-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of Non Receptive Endometrium in Obese Women
NCT02205866
Development of a Microbiome Non-invasive Diagnosis Tool
NCT03330444
Predicting Endometrial Receptivity for Optimal Reproductive Management
NCT04107129
Endometrial Gene Expression in Different Protocols of Endometrial Preparation for Embryo Transfer'
NCT02280798
Serum and Peritoneal Fluid Bank for Endometriosis Markers
NCT00194233
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lipids
Lipid identification
The lipids are identified using Mass Spectrometry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lipid identification
The lipids are identified using Mass Spectrometry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Regular menstrual cycles
* no abnormal karyotype
* generally healthy
* BMI 19-29 Kg/m2 (both inclusive)
* 18 to 35 years old.
Exclusion Criteria
18 Years
35 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Igenomix
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Carlos Simon
Prof. Carlos Simon, MD PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IVI Valencia
Valencia, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1002-C-069-OB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.